
follow zbh earn updat sales/ep estim
cc sell day sd
cc sd given
favor lower gm om estim compar consensu
guidanc
 cc lower pt
in-lin ep estim month henc
estim chang lower sales/ep
cc cc sd adj cc
sd adj given lower sale modest previous
expect improv gm sg slightli off-set lower tax rate
estim compar consensu report
valuat thesi risk past month larg coincid
new ceo prospect posit chang trade
rel forward multipl rel valuat model
regress year anticip top-lin trajectori zbh case actual
suggest lower rel forward multipl target price
will stretch regard rel forward multipl award
time forward ep base likelihood improv
oper perform believ full product suppli key
new product introduct inclus partial knee cement-less knee
new revis knee rosa orthoped robot appear us
repres seriou effort compani show increas sale
momentum like attain consist growth
also model modicum leverag improv bp
level beyond point compani undoubtedli reconfigur
portfolio lessen depend low singl digit major joint market
seek aggress leverag proven commerci organ non-
major joint product somewhat problemat latter regard fact
unencumb wont begin substanti due debt
servic although sale dental could help albeit measur ebitda
cost risk includ execut misstep inclus failur
remedi product suppli shortfal under-perform vs end market
perhap sluggish anticip major joint market
tr target
note number restat per fasb guidelin asu asu regard revenu recognit pension
page
page
million except per share interest expens inc analysisgross cmf sale sale cc/sd/divest sale inc inc
zimmer lead player musculoskelet devic segment player hip
ww share knee meaning presenc musculoskelet categori dental
cmf/thorac surgic sport medicin extrem trauma
spine ex-ldrh spun parent august headquart
believ full product suppli key new product introduct inclus partial knee
cement-less knee new revis knee rosa orthoped robot appear us
repres seriou effort compani show increas sale momentum
like attain consist growth also model modicum leverag
improv bp level beyond point compani undoubtedli
reconfigur portfolio lessen depend low singl digit major joint market seek
aggress leverag proven commerci organ non-major joint product somewhat
problemat latter regard fact unencumb wont begin substanti
due debt servic although sale dental could help albeit measur ebitda cost
valuat risk
rel valuat model regress year anticip top-lin trajectori zbh case
actual suggest lower rel forward multipl target price will
stretch regard rel forward multipl award time forward
ep base likelihood improv oper perform risk includ execut
misstep inclus failur remedi product suppli shortfal under-perform vs end market
perhap sluggish anticip major joint market
compani mention note
bruce nudel herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
